Use this link to get back to this page.

Skip to Content

Open Access User

Library Information

Library Website

View Gale Product Menu

Sign in bar

Access through your library

Select Language English

Items in Highlights & Notes may not have been saved to Google Drive™ or Microsoft OneDrive™. Are you sure you want to logout?

Gale Academic OneFile Select

Toolbar

Please select the search index

Advanced Search

Send to...

Download

Print

Get Link

Highlights and Notes

Your session has timed out after 20 minutes of inactivity. If you do not click continue session, you will be logged out in 60 secondsYour session has timed out after 20 minutes of inactivity. If you do not click continue session, you will be logged out in 60 seconds

Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid DependenceA Randomized Clinical Noninferiority Trial

Citation metadata

Authors: Lars Tanum, Krist KlemmetsbyAaAeAeA Solli and Zill-e-Huma Latif

Date: Dec. 2017

From: JAMA Psychiatry(Vol. 74, Issue 12)

Publisher: American Medical Association

Document Type: Article

Document controls

Translate

Document Translation

Format Options:

Save to Google Drive™
Save to OneDrive™
HTML

Translate Article

Set Interface Language

Colors:

Font:

Open SansEB GaramondOpen DyslexicNoto Sans

DefaultMoreMost

Line Spacing

Letter Spacing

Word Spacing

Send to Google Drive™

Send to Microsoft OneDrive™

Email

Download

Print

Main content

Source Citation

Source Citation

Gale Document Number: GALE|A520385142

Explore

Related Subjects

Buprenorphine
Naltrexone
Treatment outcome

Footer

About

Help
Dictionary
Contact Us
Terms of Use
Privacy Policy
Accessibility
End Session